As of Feb. 13, 2020, there were 15 cases of the new coronavirus in the United States, with 13 of them infected travelers returning from Wuhan, China. There is concern that the community spread could continue, even as travel from China is being checked aggressively.
Rigorous adherence to infection control measures is critical as a novel coronavirus (2019-nCoV) continues to emerge globally, threatening to transmit in the community and hospitals in the absence of an effective treatment or a vaccine, the Centers for Disease Control and Prevention emphasizes.
Although once thought of almost exclusively as a hospital-acquired condition, Clostridioides difficile has established a presence in the community that means about 10% of incoming patients could be carrying it asymptomatically, a new study finds.
The 2019-2020 flu season is already among us, and it is imperative that those healthcare practitioners on the frontline, particularly in our nation’s emergency departments, have current knowledge of prevention and treatment strategies.
Relative to vancomycin or metronidazole treatment of recurrent Clostridioides difficile infection, treatment with fecal microbiota transplantation is associated with a lower risk of bloodstream infection, shorter hospital length of stay, and improved survival.